SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Board appointments

31 Mar 2014 07:00

RNS Number : 5183D
Frontier IP Group plc
31 March 2014
 



 

AIM: FIPP

 

Frontier IP Group plc

("Frontier IP" or "the Company")

 

Board changes

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce two Board appointments, which both take immediate effect. James Fish has been appointed to the Company as Finance Director and Michael Bourne has been appointed to the Company as a Non-Executive Director.

 

James Fish, a chartered accountant, has over 25 years' experience in senior financial positions and a wide range of commercial experience including venture capital funded small/medium-sized enterprises and start-up companies. He was latterly interim Finance Director at The One Place Capital Limited, an online technology start-up. He qualified as a chartered accountant with KPMG and holds a degree in Accounting and Finance from Heriot Watt University, Edinburgh. James's appointment enables Marilyn Cole to step down as Finance Director and Company Secretary. James will also be appointed Company Secretary.

 

Michael Bourne has almost 30 years' experience in investment management and particular expertise in technology, life sciences and clean technology. He is currently Partner of Accretion Capital LLP and a Director of Cygna Negra Limited and Cygna Negra Malta Limited. He is also an Advisory Board Member of V2R, the US technology transfer venture company. Prior to these roles, in 1995, he founded asset management company, Reabourne Technology Investments Limited, where he was also Chief Investment Officer. For nine years until 2009, he was also a member of the techMARK Advisory Committee.

 

Neil Crabb, Chief Executive of Frontier IP, said,

 

"We are delightedto welcome Jim as Finance Director and Mike as a Non-executive Director. Their appointments strengthen our Board as we continue Frontier IP's development.

 

Jim brings over 25 years' experience as a senior finance professional and his involvement with start-up companies as well as venture capital funded SMEs is especially useful. Mike has substantial experience in investment management and his expertise in the clean energy and life sciences sectors also represents an excellent fit with Frontier IP's activities.

 

As well as welcoming Jim and Mike, I would also like to acknowledge Marilyn's significant contribution to Frontier IP during her time as Finance Director of the Company. She leaves with the Board's best wishes and grateful thanks."

 

The following information is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

James Milne Fish, aged 56, is or has been a director or partner of the following companies during the previous five years:

 

Current Directorships / Partnerships:

Directorships / Partnerships held within the previous five years:

FD Support Limited

 

In addition, as an interim finance director, Mr Fish has undertaken in the previous five years a finance director role with The One Place Capital Limited, McLaren Software Group Limited and Photo Therapeutics Group Limited. Photo Therapeutics Group Limited entered into a Voluntary Members Liquidation in March 2009, after the return of funds to shareholders following a trade sale of the operating subsidiary.

 

Mr Fish is a member of the Institute of Chartered Accountants of Scotland.

 

Mr Fish currently has no beneficial interest in the share capital of the Company.

 

There are no other matters which are required to be announced with regard to the appointment of Mr Fish under paragraph (g) of Schedule 2 of the AIM Rules.

 

Michael Gerald Bourne, aged 55, is or has been a director or partner of the following companies during the previous five years:

 

Current Directorships / Partnerships:

Directorships / Partnerships held within the previous five years:

Accretion Capital LLP

MGB Technology Consulting Ltd

Coombe Wood Lawn Tennis Club Limited

Cygna Negra Limited

Cygna Negra Malta Limited

 

Mr Bourne currently has no beneficial interest in the share capital of the Company.

 

There are no other matters which are required to be announced with regard to the appointment of Mr Bourne under paragraph (g) of Schedule 2 of the AIM Rules.

 

 

Enquiries

 

Frontier IP Group Plc

0131 220 9491

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

020 7894 7000

Mark Percy / Catherine Leftley, Corporate Finance

David Banks / Paul Jewell, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

020 7469 0935

Jon Levinson / Lucy Williams

KTZ Communications

020 3178 6378

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IPspecialises in the commercialisation of Intellectual Property. It establishes partnerships with individual universities and research institutions to assist with their spin-out and licensing activities and helps to maximise the commercial value of technologies emerging from their research programmes. www.frontierip.co.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADVLFLZXFEBBK
Date   Source Headline
17th Mar 20203:15 pmRNSNotice of interim results
13th Mar 20207:00 amRNSPortfolio news – The Vaccine Group Update
12th Mar 202011:05 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
19th Feb 202012:37 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSCRIL wins EUR140,000 EU Graphene Flagship funding
12th Feb 20207:00 amRNSPortfolio news - FIPP increases stake in Celerum
31st Jan 20207:00 amRNSPortfolio news - Exscientia
20th Jan 20207:00 amRNSPortfolio news - The Vaccine Group raises £680,000
16th Jan 20203:28 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSFieldwork Robotics secures first equity funding
10th Jan 20207:00 amRNSExscientia enters collaboration with Bayer AG
31st Dec 20191:00 pmRNSTotal Voting Rights
16th Dec 201910:36 amRNSExercise of Options and Issue of Equity
11th Dec 20196:03 pmRNSHolding(s) in Company
9th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:21 pmRNSHolding(s) in Company
9th Dec 20192:08 pmRNSHolding(s) in Company
9th Dec 20199:46 amRNSHolding(s) in Company
9th Dec 20197:00 amRNSGrant of Options
6th Dec 20196:25 pmRNSHolding(s) in Company
5th Dec 201912:00 pmRNSHolding(s) in Company
4th Dec 201912:00 pmRNSResult of AGM & Total Voting Rights
26th Nov 201912:58 pmRNSHolding(s) in Company
13th Nov 20195:00 pmRNSPosting of Annual Report and Accounts
7th Nov 201912:20 pmRNSHolding(s) in Company
6th Nov 20192:00 pmRNSResult of Placing
6th Nov 20197:01 amRNSProposed fundraising of £3.5m by way of Placing
6th Nov 20197:00 amRNSFinal Results
22nd Oct 20197:00 amRNSAppointment of senior advisers
15th Oct 20197:00 amRNSNew portfolio company: Elute Intelligence Holdings
10th Sep 20197:00 amRNSAppointment of Broker
25th Jul 20197:00 amRNSExscientia collaboration with Rallybio
15th Jul 201912:08 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSExscientia partnership with GT Apeiron
31st May 20195:00 pmRNSTotal Voting Rights
31st May 20193:15 pmRNSDirectorate Change
28th May 20197:00 amRNSFieldwork Robotics completes initial field trials
15th May 20197:00 amRNSDirector exercise of options, shareholding and TVR
10th May 201911:48 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSEuropean plan to boost marine & coastal economies
8th Apr 20197:00 amRNSParkside Architectural Tiles launch Alusid range
8th Apr 20197:00 amRNSInvestor event at the Royal Academy of Engineering
8th Apr 20197:00 amRNSBosch UK to work with Pulsiv Solar
4th Apr 20197:00 amRNSExscientia reaches first major milestone with GSK
3rd Apr 20195:51 pmRNSHolding(s) in Company
3rd Apr 20193:45 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSFieldwork Robotics wins Innovate UK ISCF grant
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20191:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.